School of Biomedical Sciences
Research Questions
- How do cancers take control of our body and develop into a deadly disease?
- Where do stem cells come from and how can we harness their potential for regenerative medicine?
- How can the mouse as a model organism provide answers and therapies to human diseases?
- Can big data transform biomedical discovery and digital healthcare?
- How does our brain work or fail to work in events such as aging, cognitive disorders and neurodegeneration?
- How can we design, evolve and engineer molecules, circuits and systems for a next generation of therapeutics and diagnostics?
Research Areas
1. Brain and Cognitive Sciences
Cognitive functions are orchestrated by neurons and glial cells in different regions of the brain, and represent one of the major issues in neurodegenerative diseases and brain disorders. Our School collaboratively investigates the molecular events that support cognitive functions, including the formation and retraction of synapses, dendrites and axons. We use zebrafish, Xenopus, rat, and mouse as genetic model organisms to investigate neurodevelopment, neuromuscular junction formation, physiological functions of neurons and glial cells, neuroinflammation, and pathological mechanisms that lead to neurodegeneration and neurocognitive disorders. We also assess the value of deep brain stimulation, neuroprotective effects from exercise and diet, and the potential utility of stem cells in neuroregeneration.
| Supervisor(s) | Research Interest |
|---|---|
|
Neurodegeneration; Neuroimmunology; Alzheimer's disease; Parkinson's disease dementia; Microglia; Neuroprotection; Post-operative cognitive dysfunctions |
|
|
Neural development; Modelling neurological diseases and melanoma |
|
|
Hypoxia physiology |
|
|
Functional protein aggregation; Functional amyloids; Electron-cryo microscopy; Memory persistence; Cellular memory |
|
|
Synthetic biology; Vaccines for infectious diseases and cancers; Biological pattern formation |
|
|
DNA repair; Genome stability; DNA damage responses; Cell cycle checkpoint control |
|
|
Protein design and stem cell engineering; Directed molecular evolution in mammalian cells |
|
|
Two-photon in vivo imaging; Learning and memory; Synaptic plasticity |
|
|
Extracellular matrix remodelling in synapse development and disease |
|
|
Behavioural, cellular and molecular neuroscience; Neuromodulation in psychiatric and neurodegenerative disorders |
|
|
Human genetics; Bioinformatics and functional genomics |
2. Cell Signalling and Cancer Biology
Cell signalling defines the means via which cells sense and respond to internal and external cues, and is fundamental to cell proliferation and survival, cell-cell communication, and cell differentiation and organismal development. For instance, when cells detect changes in nutrient levels within its microenvironment a cascade of signalling events would ensue such that cell and tissue homeostasis can be maintained. One important focus of study within our School is cell signalling and how its alteration can lead to diseases including cancer. Members of our School are also researching on a wide variety of aspects of biology implicated in the origin and growth of cancer, including cancer stem cell and self-renewal, DNA replication and repair, metabolism, metastasis, cell cycle and immune escape.
| Supervisor(s) | Research Interest |
|---|---|
|
Molecular virology and innate immunity; Molecular biology and transcriptional regulation |
|
|
Cancer driver mutations; Cancer signalling; Drug sensitivity and resistance mechanisms |
|
|
Neural development; Modelling neurological diseases and melanoma |
|
|
Centrosome biogenesis; Rho signalling; Chromosome instability and cancer metastasis |
|
|
Chemical biology; Proteomics; Mass spectrometry; Molecular imaging; Medicinal chemistry |
|
|
Hypoxia physiology |
|
|
Cell signalling in development and disease; Genetic and molecular basis of skeletal disorders |
|
|
Tissue development and regeneration; Mouse genetics and human organoids for disease modelling |
|
|
DNA repair; Genome stability; DNA damage responses; Cell cycle checkpoint control |
|
|
Multi-omics analysis of cancers and rare diseases; Computational biology |
|
|
Molecular virology and oncology |
|
|
RNA biology and genome engineering |
|
|
Stem cells; Genetics and genomics; Developmental Biology; Haematopoiesis and immune cell functions; Cancer cell killers; Cell-based therapies |
|
|
Cancer stem cells; Tumour microenvironment; Drug resistance; Targeted therapy; Liver cancer; Basic/translational cancer research |
|
|
Epigenetics and genome instability; Structural biology |
|
|
Organoids and stem cells; Cell engineering; Immunology; Cancer immunotherapy |
|
|
Cancer targeted therapy; Therapy resistance and cancer stemness |
|
|
Genome editing; Protein engineering; Synthetic biology; Combinatorial genetics; Drug target discovery; Disease biology |
|
|
Cancer genomics; Proteomics and bioinformatics |
|
|
Cell adhesion and cytoskeleton regulation; Podosome and invadopodium; Mechanobiology; Phosphatidylinositol signalling; Fluorescence microscopy |
|
|
Stem cell self-renewal and differentiation in development; Aging and cancer |
3. Genomics and Biomedical Data Sciences
Technological advances in genomics, proteomics, metabolomics, imaging, and access to a wide variety of digital health data in electronic health records, require a big data approach to scientific discovery and digital health innovation. Our School has expertise in developing and applying state-of-the-art statistical and computational methods to harness these big data to address a variety of biomedical problems. Key research areas include discovery of mutational signatures in cancer genomes, discovery of rare stem cell populations in cancers using single cell transcriptomic data, identification of causal mutations and the developmental origin of rare diseases, discovery of how altered gut microbiome can impact health, the use of metabolomics and proteomics technologies to identify novel disease biomarkers, and use of wearable devices, smartphones and artificial intelligence in modern digital healthcare.
| Supervisor(s) | Research Interest |
|---|---|
|
Skeletal and matrix biology; Animal models of diseases; Stem cells and regeneration |
|
|
Bioinformatics; Artificial intelligence; Medical big data; Digital health technology; Metagenomics; Single cell genomics |
|
|
Bioinformatics; Single-cell genomics; Statistical modelling |
|
|
Multi-omics analysis of cancers and rare diseases; Computational biology |
|
|
Stem cells; Genetics and genomics; Developmental Biology; Haematopoiesis and immune cell functions; Cancer cell killers; Cell-based therapies |
|
|
Human genetics; Bioinformatics and functional genomics |
|
|
Advance virology and immunology by integrating genomic, proteomic, structural, quantitative, and deep learning approaches |
|
|
Cancer genomics; Proteomics and bioinformatics |
4. Stem cell, molecular and developmental genetics
Research in developmental biology provides invaluable insights into the molecular events that underlie the diverse cellular changes as tissues and organs are formed during embryogenesis. However, as tissues and organs are formed from a single totipotent stem cell, namely the fertilized zygote, that undergoes well-defined cell divisions and progressive lineage differentiation to specific cell types in the body, it is tightly linked to stem cell biology. Further, it also links to the study of rare diseases where mutations in specific genes can result in developmental defects. Thus, this research area of the School in stem cell biology, developmental biology and functional genetics work hand in hand to resolve complex questions in understanding disease mechanisms, control of stem cell differentiation and cell function, with the opportunity to provide therapeutic interventions through drug discoveries and application of regenerative medicine. Specific areas of focus include musculoskeletal, neurological, metabolic, and ageing defects.
| Supervisor(s) | Research Interest |
|---|---|
|
Skeletal and matrix biology; Animal models of diseases; Stem cells and regeneration |
|
|
Neural development; Modelling neurological diseases and melanoma |
|
|
Cell signalling in development and disease; Genetic and molecular basis of skeletal disorders |
|
|
Tissue development and regeneration; Mouse genetics and human organoids for disease modelling |
|
|
Synthetic biology; Vaccines for infectious diseases and cancers; Biological pattern formation |
|
|
Protein and stem cell engineering |
|
|
RNA biology and genome engineering |
|
|
Metabolic reprogramming of T cells in chronic inflammatory diseases |
|
|
Stem cells; Genetics and genomics; Developmental Biology; Haematopoiesis and immune cell functions; Cancer cell killers; Cell-based therapies |
|
|
Human genetics; Bioinformatics and functional genomics |
|
|
Employing fluorescence and electron microscopy to dissect the function of microtubules and microtubule-associated proteins |
|
|
Secreted PDZD2 as novel regulator of Hedgehog signalling; FOXM1 and regulation of stem cell function |
|
|
Cell biology of adhesion and cytoskeleton regulations; Fluorescence microscopy; Mechanobiology; Podosomes and cancer invadopodia |
|
|
Stem cell self-renewal and differentiation in development; Aging and cancer |
5. Stem Cell, Molecular and Developmental Genetics
A transdisciplinary understanding of biomolecule function at the atomic level provides insights into the molecular biology underlying all of life and medicine. We are now moving from observations of the structure and dynamics of molecular complexes and machines (structural biology), towards perturbing these systems (chemical biology), through to re-engineering biomolecules by both rational design and evolution (synthetic biology). Our School has deep expertise in these areas - integrating structural biology with functional proteomics, nucleic acid evolution with translational technology, and artificial biological circuits with genome engineering. Such approaches are allowing new ways to better understand biology and medicine, and allow translational angles across therapeutics, diagnostics and bioengineering.
| Supervisor(s) | Research Interest |
|---|---|
|
Chemical biology; Proteomics; Mass spectrometry; Molecular imaging; Medicinal chemistry |
|
|
Structural biology; Synchrotron radiation methods; Epigenetic regulators |
|
|
Synthetic biology; Vaccines for infectious diseases and cancers; Biological pattern formation |
|
|
Protein and stem cell engineering |
|
|
Epigenetics and genome instability; Structural biology |
|
|
Advance virology and development biology by integrating quantitative, structural, genomic, proteomic and immunological approaches |
|
|
Nucleic acid nanotechnology and chemical biology |
|
|
Genome editing; Protein engineering; Synthetic biology; Combinatorial genetics; Drug target discovery; Disease biology |
|
|
Cancer genomics; Proteomics and bioinformatics |
Next Step?
For more information or to express interest to join the research areas, please email the supervisor or the specified contact point in the description. Interested candidates are advised to enclose with your email:
- your CV,
- a brief description of your research interest and experience, and
- two reference letters (not required for HKUMed UG students seeking MRes[Med]/
URIS projects).
Research postgraduate studies enquiries specific to the department/school’s research should be directed to the Departmental Research Postgraduate Advisor:
Dr RCC Chang
rccchang@hku.hk
Information on the research programme, funding support and admission documentations could be referenced online at the Research Postgraduate Admissions website.
General admission enquiries should be directed to rpgmed@hku.hk.
Our Students
Jane LOONG
Place of Origin: Hong Kong
Progress: PhD Year 4
Primary supervisor: Dr SKY Ma
“You'll go through lots of failures throughout your studies, but it's not the end of the world when things don't work out.”
Now in the process of finishing up her thesis, Jane Loong (Year 4 PhD student from the School of Biomedical Sciences) took some time to reflect on her PhD journey. Her word of advice to those just starting out? To stay organised; "Properly filing the papers you read and document the protocols you had will make your life easier throughout your studies!"
As a member of the SMA Lab, Jane works alongside a group of labmates, post-docs and supervisors, all of whom have played a key role in her postgraduate career by guiding her through technical hurdles and challenges throughout her research.
"Communication between labmates is very important when it comes to exchanging ideas about my current research topic. I like to chat with them to ask for advice whenever I am stuck with my project or experiment…it is through these discussions that we are able to identify ideal solutions.”
Jane's study highlights the therapeutic potential of FUT1 to treat nutrient-deprived tumors and hopefully provides a rationale for the future design of small molecule inhibitors against FUT1 and treat tumors by eradicating the cancer stemness subset.
June 2021
Victor GRAY
Place of Origin: France
Progress: PhD Year 2
Primary supervisor: Dr HGS Ling
"Your supervisor will be the person from whom you may seek the most support, so it’s important to build a strong foundation early on".
As a budding researcher and academic, Victor Gray believes in the importance of developing a good relationship with one’s supervisor, as they often have much wisdom to impart on how to deal with stress and future planning, "They have been through what you are currently going through, so they naturally have lots of advice to give you”.
Coming from the UK with an interest in immunology, he looked forward to fine-tuning his research skills under Dr Ling Guang Sheng; “She is someone who has shown expertise in the field for a number of years back in my home country, so I'm very excited to be a part of this transition of immunology research at HKUMed as our team expands”.
Victor now hopes to study in greater detail how various environmental conditions affect the metabolic properties of immune cells, and identify metabolic pathways which may be targeted in order to boost immune responses; "This is especially relevant in the context of cancer and chronic viral infections, where the metabolic properties of immune cells play a crucial role in the outcome of these conditions”.
January 2021
Jessie HO
Place of Origin: Hong Kong
Progress: PhD Year 2
Supervisor: Dr R Jauch
“As someone who is easily stressed and anxious, pursuing my hobbies and passions outside of the lab have been critical in helping me reduce my stress to a manageable level”
Living up to the mantra of ‘work-life balance’, Jessie Ho, a Year 2 PhD student, remained active in a plethora of hobbies before the pandemic, “I am an avid tennis player; I began playing Quidditch with Hongkong Hydras; I practiced and performed with my band and the Lap-Chee Acapella Team at the Residential Colleges; I also made sure that Saturday nights and Sunday mornings were reserved for spending time with my family.”
Though many postgraduate students often find themselves buried in work, Jessie believes in the importance of healthily managing stress, especially when pursuing academia. “There have been times where I have felt overwhelmed, which can translate into technical errors and lead to unusable data, so these hobbies have been critical in helping me reduce my stress to a manageable level.” This is all the more important, given that “high-quality research takes time to plan and execute”, Jessie added.
“I do not believe having research completely consume one’s life...that is why I try to make an effort to relax and enjoy my hobbies, and most importantly spend time with the people I care about.”
December 2020
Maja SØRENSEN
Place of Origin: Denmark
Progress: PhD Year 3
Supervisor: Dr RCC Chang
"The drive here in Hong Kong is so different…everything works at a much faster pace here compared to back home”.
For Maja, a second year PhD student from Denmark, the initial culture shock of working in Hong Kong left an impactful impression, "It's faster, everything just works so much faster research-wise - you produce so many more results daily, compared to back home…but also the research is quite interesting here".
Luckily, she's taken a liking to the fast-paced culture here as it pushes advancement in her current research. She hopes that her work could take her one step closer into achieving her goal of improving life quality for patients with Parkinson's Disease. "It always motivates me if I can make life a bit better or easier for other people. So, if we could help slow down a degenerative disease and its spread in the brain…that would make me feel better about the value of my work".
June 2020
Zurn KUWENTRAI
Place of Origin: Thailand
Progress: PhD Year 3
Supervisor: Professor JD Huang
“…The way I look at my PhD, it's a stepping stone that will build up my resume but also my research experience…”
For Zurn Kuwentrai, a first-year PhD student at the School of Biomedical Sciences from Thailand, his postgraduate studies at HKU marks his first foray into the world of academia which is full of challenges but also many new opportunities. “I have had very little research experience [so] my PhD research is very new to me…essentially I'm learning everything in one go during my first year."
Zurn also values being able to pursue his PhD on his own terms, without the pressures of preconceived expectations, “My goals are slightly different from others; I don’t feel the absolute need to publish, or apply to be a Principle Investigator in the future. I just want to learn as much as I can and the experience here itself is…what my goal is, and I'm already getting it every single day I walk into the lab."
As for what’s next in store for Zurn, he hopes his focus on mRNA therapeutics will allow greater accessibility to treatment options for patients, “Less developed countries find it very difficult to afford protein therapies, so we are currently developing ways to make our mRNA therapies equally good so that one day, it can be in the market as well."
June 2020
Daisy TAN
Place of Origin: Philippines
Progress: PhD Year 1
Supervisor: Dr R Jauch
“We all find it quite funny hearing each other’s stories from our respective home countries – something like having to buy your own reagents and distilled water like I did for my experiments is unheard of to my lab mates!”
Daisy Tan, an MPhil student from the Philippines, reckons that working in a diverse group of passionate researchers at her lab has been an asset to her research experience here, not only because they get to trade stories and anecdotes, but also because there’s such diversity in their skillsets too.
“We have individual meetings with each other to catch up on our respective projects, so even though we’re working on separate tasks, we can always seek the individual expertise of one another […] part of the culture here is to troubleshoot together, and learn from your fellow lab mate who may have stronger foundations in other areas of academia; take molecular biology for example, that’s something I only learnt from them after coming here”.
November 2019
Smaranda BADEA
Place of Origin: Romania
Progress: PhD Year 4
Supervisor: Professor JD Huang
Romanian-born Smaranda Badea spends the bulk of her time at the Faculty Core Facility, where she taps into the multi-million dollar advanced imaging and cellsorting technologies for her research.
Smara, who will soon be graduating with a PhD degree in Neuroscience, has been investigating the way our body responds to injuries in the nervous system.
“Our nervous system tends to react very strongly when it is damaged by injury. What we can do is try to modify how it responds, using particular pathways to calm it down, so that it will prioritise repair over the typical response that would sustain the damage,” says Smara, who hopes the findings from her research might be applied to treating other conditions such as multiple sclerosis and spinal cord injuries.
July 2019
Follow HKUMed